Trade Moderna Inc ^MRNA

FY2030 EPS Estimate for Moderna Lowered by Analyst - Zolmax

Moderna (MRNA) Gets Phase 3 Melanoma Vaccine Validation At ESMO And NEJM

A Skin Cancer Vaccine May Be on the Way as Moderna and Merck Release Promising Results

Best Biotech Stocks Worth Watching - October 26th - Markets Daily

ESMO '26: A cancer vaccine debate, Roche's KRAS progress and Amgen's 'unprecedented' data

The excitement around Moderna's cancer vaccine is cooling. Here's why. | Morningstar

Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady

Best Healthcare Stocks To Watch Today - October 26th - Stock Observer

EULAV Asset Management Acquires 9,727 Shares of Moderna, Inc. $MRNA

Moderna, Inc. $MRNA Shares Sold by IFP Advisors Inc

Brookline Capital Markets Estimates Moderna FY2030 Earnings

Merck & Co., Inc. $MRK Holdings Lessened by Sigma Planning Corp - Daily Political

Promising Healthcare Stocks To Keep An Eye On - October 25th - Markets Daily

Wells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks

Moderna (MRNA) Stock May Be Fully Priced As Melanoma Vaccine Data Leaks

Merck & Co., Inc. $MRK Stake Boosted by Norris Perne & French LLP MI - Markets Daily

Merck & Co., Inc. $MRK Position Trimmed by Middleton & Co. Inc. MA - Markets Daily

Merck & Co., Inc. $MRK Stock Bought by Norris Perne & French LLP MI - Stock Observer

Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial

Biotech stocks rally on drug innovation and M&A

Merck & Co., Inc. $MRK Holdings Decreased by Sterling Capital Management LLC - Stock Observer

Moderna investors should brace for more whiplash | World News

5,000 Shares of Moderna, Inc. $MRNA Bought by Credit Capital Investments LLC

Breakthrough Melanoma Vaccine from Merck and Moderna Reduces Death Risk by 42%, ETPharma

Moderna (NASDAQ:MRNA) Shares Down 1.2% - Time to Sell?

Moderna stock extends losses as investors digest melanoma vaccine trial data

Think annuities are a rip-off? Now might be the perfect time to reconsider. | Morningstar

Health Matters: Vaccine shows positive signs for melanoma patients

Oncologists Cheer Melanoma Data That Tanked Moderna's Shares (1)

Doctors call Moderna, Merck cancer vaccine data a major advancement - despite Wall Street reaction

William Blair analyst on Moderna's stock plunge following cancer vaccine data leaks

Moderna trims losses as investors digest melanoma vaccine trial data

Interpath-100: data leak, stock drop, spirited defense by ESMO president

Personalized mRNA Vaccine Cuts Melanoma Death Or Recurrence Risk 42%

Moderna stock extends decline after leaked data on melanoma vaccine trial

Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip

Promising Healthcare Stocks To Consider - October 23rd - Stock Observer

Did You Lose Money on Moderna, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 23.07% Share Price Decline | Morningstar

Moderna (MRNA) Stock Drops 17% Despite Melanoma Trial Success

Stocks making the biggest moves premarket: AT&T, SpaceX, Moderna, Deckers, Bloom Energy and more

Capital Group Global Growth (CGGO) Buys $121.1 Million More Moderna on Oct. 21

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

Dow Jones Top Company Headlines at 1 AM ET: SK Hynix Shelves Memory-Chip Unit U.S. IPO Plan on Market Jitters | Moderna's ... | Morningstar

After Moderna's 672% Climb, The Story Has Changed

Moderna, Inc. (NASDAQ:MRNA) Stock Has Consensus Target Price of $101.45 According to Analysts - Stock Observer

Dow Jones Top Company Headlines at 11 PM ET: SK Hynix Shelves Memory-Chip Unit U.S. IPO Plan on Market Jitters | Moderna's ... | Morningstar

Moderna's $24 Billion Loss: Analysts Attribute Drop to 'Sell-the-News' After Cancer Vaccine Results, ETPharma

Moderna stock's 17% slump was a 'sell the news' event, analyst says

Personalized mRNA vaccine lowers melanoma risk

Oncologists cheer melanoma data that tanked Moderna's shares | News & Features | ArcaMax Publishing

Moderna mRNA vaccine almost halves the risk of skin cancer returning

A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

AI Selloff Gains Steam but Solid Market Action Beneath the Surface

Dow Jones Top Company Headlines at 7 PM ET: Moderna's Stock Plummets After Cancer-Vaccine Data Shared on Social Media | American ... | Morningstar

Moderna shares plunge as leaked cancer vaccine data disappoints

Moderna (NASDAQ:MRNA) Shares Down 17.6% - Time to Sell?

Mizuho's Jared Holz: Moderna drop reflects high bar, not bad data

Moderna, Merck Shares Fall As Leaked Cancer Data Disappoints

Health Care Cos Up on Defensive Bias - Health Care Roundup | Morningstar

Moderna Stock Plunges 18% As Leaked Melanoma Vaccine Data Underperforms

Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data

Moderna's cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled | Morningstar

Moderna plunges on leaked vaccine data, Musk to invest $1B in Skydance, Spotify surges

Moderna Shares Plunge After Leak of Cancer Vaccine Data

Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat

Moderna's cancer vaccine hits its targets, but an embargo breach rattles investors and the stock tumbles | Morningstar

Moderna, Merck shares fall on eagerly anticipated cancer vaccine results

Dow Jones Top Company Headlines at 3 PM ET: Moderna's Shares Plummet After Cancer-Vaccine Data Shared on Social Media | American ... | Morningstar

Moderna stock crashes as leaked melanoma data threatens its record August rally

Moderna, Merck Shares Fall After Melanoma Data Was Leaked

Moderns shares plunge on partial leak of cancer vaccine data

Moderna shares plunge after leak of partial cancer vaccine data

Moderna's stock tumbles after reported leak of data for cancer vaccine | Morningstar

Moderna Tumbles 25% After Apparent Early Leak of Melanoma Vaccine Data; BioNTech Dips, Pfizer Edges Higher

Moderna shares plunge on apparent cancer vaccine data leak

Moderna, Merck Shares Fall After Possible Melanoma Data Leak

Top Biotech Stocks To Consider - October 22nd - Markets Daily

Moderna has a plan to revolutionize how certain cancers are treated. We're about to find out its potential in melanoma. | Morningstar

US stocks 2026: Moderna, SanDisk lead top 10 gainers delivering up to 734% returns

Invesco S&P 500 Equal Weight ETF (RSP) Sells $0.7 Million of Moderna on Tuesday

Moderna (MRNA), Why Is The Company Drawing Fresh Attention?

Best Healthcare Stocks To Research - October 22nd - Daily Political

Is Moderna (MRNA) Fully Valued Following Its NASDAQ 100 Inclusion?

Moderna (NASDAQ:MRNA) Reaches New 12-Month High - Still a Buy? - Daily Political

Moderna (NASDAQ:MRNA) Stock Jumps 1.5% After Analyst Upgrade

Top Healthcare Stocks To Follow Today - October 21st - Zolmax

Moderna (NASDAQ:MRNA) Stock Gets Price Target Bump from TD Cowen

Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. | Morningstar

Moderna (NASDAQ:MRNA) Shares Up 4.1% - What's Next? - Markets Daily

Invesco S&P 500 Equal Weight (RSP) Sells $1.1 Million of Moderna on Monday

Biotech Stocks To Keep An Eye On - October 18th - Stock Observer

Moderna (NASDAQ:MRNA) Shares Up 6.7% - What's Next?

Dow leads Wall Street higher, investors focus on healthcare stocks

Moderna (NASDAQ:MRNA) Sets New 1-Year High - Here's What Happened

Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%

Should Leadership Hire Require Action From Everest Medicines (SEHK:1952) Investors?

Bank Pictet & Cie Europe AG Sells 6,591 Shares of Moderna, Inc. $MRNA

Moderna Shares Fall 18% After Cancer Vaccine Data Leak Triggers Sell-Off

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Moderna Stock Rebounds 4.81% as Cancer Vaccine Focus Builds Ahead of Nasdaq-100 Return

Moderna Stock Surges 12% as ESMO Spotlight Builds Around Cancer Vaccine Data

Is SpaceX a Good Stock to Buy in 2026?

Moderna Stock Soars 177% as Cancer Vaccine Delivers a Landmark Phase 3 Win

Broadcom Stock Rises 4% as $63 Billion Anthropic Financing Supports AI Outlook

AMD Stock Rises 5.45% as Meta Partnership Advances Ahead of Earnings

Oil Price Today: Brent Tops $115 as Saudi Refinery Attack Claim Revives Supply Fears

Microsoft and Alphabet Earnings Today: Can AI Cloud Growth Outrun Surging Capex?

Gold Price Today: Bullion Slips Near $4,045 Ahead of Fed Decision

SK hynix Q3 2026 Results and Shareholder Returns

SK Hynix Earnings Beat Forecasts as HBM4 Drives an 80% Margin and Record Profit

Gold Price Today Holds Near $4,010 Ahead of Fed Decision